Thus, a high expression of lncRNA H19 and APOBEC3G may be considered as novel diagnostic markers in pancreatic cancer and sulforaphane analogues may be suited for the development of new and effective drugs for treatment of PDAC and other tumor entities. The gene discussed is APOBEC3G; the disease is familial pancreatic carcinoma.